Chinese vaccine maker Sinovac saw sales in the first half of 2021 explode to more than 160 times what they were a year earlier, but cautioned future revenue could slip amid competition from other Covid-19 shots https://t.co/2foaEVVJBK
— Bloomberg (@business) December 31, 2021
Source: Twitter
Discover more from #News247WorldPress
Subscribe to get the latest posts sent to your email.

